Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice - Wikidata - thesis-toulmin - TriplyDB

Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice

Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice

http://www.wikidata.org/entity/Q35753067

about

Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities Metabolic Flexibility and Dysfunction in Cardiovascular Cells Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease Lipids and the endothelium: bidirectional interactions Insulin resistance, hyperglycemia, and atherosclerosis A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.Dual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats.Protective Pleiotropic Effect of Flavonoids on NAD⁺ Levels in Endothelial Cells Exposed to High Glucose.Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.Aldose reductase, oxidative stress, and diabetic mellitus.The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice.SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa cells under Osmotic Stress: In Vitro and In Silico Insights.Aldose reductase, oxidative stress and diabetic cardiovascular complications Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients.Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals.Aldose reductase meets histone acetylation: a new role for an old player.2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?Metabolic Regulation of Angiogenesis in Diabetes and Aging.Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia.Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.Mechanism of capsaicin inhibition of aldose reductase activity.Endothelial Cell Metabolism.Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice

P2860

Q26744840-F175C692-954C-4C92-AFF2-8600A121BD79 Q26796679-10C763B2-46C7-46A3-B565-F3C95FF54EC3 Q26822630-C78F8F41-DA34-4276-B535-2B097ADFA0A7 Q26859449-4B40E849-C7B4-431A-B673-6BD387E6B6B9 Q26860086-24EF2233-1CFA-4106-8BAF-63EF6438AA20 Q27011696-0BD8E23A-0396-48E2-AD16-E1AB474A79F4 Q28382891-9A8CD7BC-6FE2-444E-84BD-F56C4DF8547C Q28395675-121E94E6-2669-448D-BDA2-F56CE5888864 Q34431401-9C5B40D2-008F-4351-917C-424C7FFF690F Q35654369-0FDB0576-552D-4133-89DB-7F607E20FA3B Q35769224-B0ED6828-BB3D-4443-8FA5-49238C91F02C Q35830289-4C14E6BB-73AF-4A96-911C-348165DC135E Q35947855-940F09D5-B7C0-4531-80D3-62D0AE8530C6 Q36018270-F2637AAF-AC95-4664-9350-6FF92B0FD8A2 Q36106728-98AFDE2D-0573-4DD9-9094-DE01897E0245 Q36777049-5F8905AF-DFE7-4E35-9591-CC257FFFF317 Q37292061-66AE4E71-BFB0-4456-B2E3-F0C3BA93A2F7 Q37510157-0466C640-BD19-46F8-8DE6-46946D240D1F Q37510190-D1D4C02B-DBE9-43DC-BB41-63B5B878A08E Q37666671-0704B925-AD9A-4B04-9B9F-0E991B96AB67 Q38059912-642CD985-E3CB-4581-8BF9-D5217D5A15AF Q38620860-D8745104-D8CE-45FF-833A-37E812105EB9 Q38882106-00C0BE4C-FD07-4BD3-9034-D4317FDF95A2 Q39373990-C8F608FF-AE3B-44DC-AB25-1D5F9E40D3CD Q39999962-C88F184C-8AB0-49FA-AD9A-53E296F3049D Q46297555-7DA2494C-8E93-4DD2-8098-4B2D300F4F53 Q48300940-440F1C91-67BD-44EC-9160-0454DEBDA2FB Q49787990-47BF4812-658E-4589-9507-8A4B6897880F Q50118982-8C68B104-FFC2-4470-80B8-457B42E10118 Q56971664-BE35D547-2D38-4310-A549-F73508352349

P2860

Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice

http://www.wikidata.org/entity/Q35753067

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@ast

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@en

type

label

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@ast

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@en

prefLabel

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@ast

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@en

P1433

Q35753067-057AD59D-221E-4276-9199-3A8931A2086F

P1476

Q35753067-70757220-ED33-4689-861C-A05A9BEF4CC4

P2093

Q35753067-14285250-5AAD-4D21-9892-74E24110FD23

Q35753067-3C177FD8-FD1E-414C-BD0B-F9E63B02A54E

Q35753067-5096A746-5F56-4EFD-8F23-B42D8B96A265

Q35753067-73EA7364-B809-4BFA-AAE0-8EDD17CF6B21

Q35753067-748DCD4A-EC2F-47B0-8075-279014D98E5C

Q35753067-761F9FFF-E7A7-4A94-B260-48D885E78EB6

Q35753067-8B9B52FE-4176-4130-A8D1-7B8F01F7B9B3

Q35753067-A48BF5E1-7320-4768-B31B-32882A00E256

Q35753067-D19CF2BB-F213-4FC9-882E-2176597DFBDC

Q35753067-DE35FD3D-113E-4069-A401-6852ED66ED64

P2860

Q35753067-0A6EBFFB-8D79-45CF-B531-B736AF9E58B0

Q35753067-0FCA5719-0E3C-4850-9BE7-34410F2A8C31

Q35753067-13B9B807-3A55-4C5A-8FB6-CAEAC4D3EA05

Q35753067-143D4219-984F-4E1A-80FE-A605CB1F19B4

Q35753067-1490C71D-A5B1-4E90-BA3C-2B9D9ACA782B

Q35753067-1B3D6ECB-32A0-40A4-8141-AD0C41ED6C34

Q35753067-1E03BE41-2CA4-4277-92F5-661B73A71B2B

Q35753067-26EBDCD7-4BEE-4253-92FD-6EE3E61E0086

Q35753067-467EDF2F-A1D5-4966-A406-6AC1400A4176

Q35753067-52BC7CDD-6ED4-4ED4-A7DA-6144EED03668

P304

Q35753067-97A9C3C3-AA13-46A7-8243-813087392398

P31

Q35753067-80351BDE-616F-4D98-BBC4-D32D33DD7DC5

P356

Q35753067-A31F2D85-D2C4-4A0D-9A82-84A9066FCFC6

P433

Q35753067-20F4577B-267E-49F7-BBA9-4E4080925082

P478

Q35753067-52370ACC-9293-4E81-B94D-3E375F546ADA

P50

Q35753067-9EBB63B7-7410-4147-AAE2-06A3CB4ECE9F

Q35753067-B85266B7-BBCA-42EF-AB9C-30E3A806E579

Q35753067-C19B7FCE-C12D-42D9-9542-9138315C6DA4

P577

Q35753067-D58365D0-D5FC-45FA-8CCB-A12BBE4C7957

P698

Q35753067-1EDEA45B-DC82-4986-A10C-02E7C8D4F13C

P921

Q35753067-2A062028-1599-47E3-925A-D69418CCAF07

P932

Q35753067-A3B6A3B1-FFF1-4996-B25D-089F8403611F

P356

ATVBAHA.111.226902

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Human aldose reductase express ...... betic apolipoprotein E-/- mice

@en

P2093

Ann Marie Schmidt

http://www.w3.org/2001/XMLSchema#string

HyeLim Noh

http://www.w3.org/2001/XMLSchema#string

Ira J Goldberg

http://www.w3.org/2001/XMLSchema#string

Kellie Hallam

http://www.w3.org/2001/XMLSchema#string

Lesley Ann Huggins

http://www.w3.org/2001/XMLSchema#string

Ni Son

http://www.w3.org/2001/XMLSchema#string

Radha Ananthakrishnan

http://www.w3.org/2001/XMLSchema#string

Rosa Rosario

http://www.w3.org/2001/XMLSchema#string

Shuiquing Yu

http://www.w3.org/2001/XMLSchema#string

Srinivasan Vedantham

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Cloning and expression of human aldose reductase

Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice

Biochemistry and molecular cell biology of diabetic complications

The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis

MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.

P304

1805-1813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.111.226902

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Thyyar Ravindranath

Konstantinos Drosatos

Ravichandran Ramasamy

P577

2011-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21636809

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3278231

http://www.w3.org/2001/XMLSchema#string